Dr Agarwals Healthcare IPO Details
The Dr Agarwals Healthcare IPO is a book build issue with a total issue size of ₹3027.26 cr, comprising of fresh issue of 7462686 equity shares., and a offer for sale of 67842284 equity shares. Dr Agarwals Healthcare IPO opened for subscription on Jan 29, 2025 and closed on Jan 31, 2025. Dr Agarwals Healthcare IPO is set price band at ₹382 to ₹402 per share, with a lot size of 35 shares. Minimum investment for Retail investors was ₹14,070.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Feb 03, 2025, and listed on both the NSE and BSE on Feb 04, 2025.
Kfin Technologies Limited has been appointed as the registrar. Morgan Stanley India Company Private Limited, Jefferies India Private Limited, Kotak Mahindra Capital Company Limited and Motilal Oswal Investment Advisors Pvt Ltd are the Book Running Lead Manager for the issue.
Before investing in the Dr Agarwals Healthcare IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 382 – 402
- Lot Size
- 35
- Issue Size
- ₹3027.26 Cr
- Minimum Investment
- ₹14070 (35 Shares)
- Listing Date
- 04 February 2025
Current GMP
₹-4 (-1.00%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited is a leading provider of eye care services in India, offering a comprehensive range of treatments including cataract surgeries, refractive surgeries (such as LASIK), and other eye-related surgeries. The company also provides consultations, diagnoses, non-surgical treatments, and sells optical products, contact lenses, and pharmaceuticals related to eye care. As of September 30, 2024, Dr. Agarwal's Health Care holds a 25% market share in India's eye care service market and operates the largest network of eye care facilities in the country, with 209 locations.
The company's network is organized in a "hub and spoke" model, consisting of 28 Tertiary Facilities (including three centers of excellence), 165 Secondary Facilities, and 53 Primary Facilities, across 117 cities in India. This model enhances accessibility and operational efficiency. Dr. Agarwal's Health Care also has an international presence, operating 16 facilities in nine African countries.
The company serves millions of patients annually, with over 2.13 million patients and 220,523 surgeries performed in FY 2024. It is projected to grow with the expanding Indian eye care market, which is expected to reach ₹550–650 billion by 2028. The company is led by Dr. Amar Agarwal, a renowned ophthalmologist with over 35 years of experience.
In addition to its eye care services, the company focuses on clinical excellence and standardization across its network, supported by a skilled team of doctors and institutional investors, including Temasek Holdings and TPG. Dr. Agarwal’s Health Care is well-positioned to continue its growth in India and internationally, capitalizing on the increasing demand for eye care services.
Dr Agarwals Healthcare IPO Promoters
- Dr. Amar Agarwal
- Dr. Athiya Agarwal
- Dr Adil Agarwal
- Dr. Anosh Agarwal
- Dr Ashvin Agarwal
- Dr. Ashar Agarwal
- Dr. Amar Agarwal Family Trust
- Dr Adil Agarwal Family Trust
- Dr. Anosh Agarwal Family Trust
- Dr Ashvin Agarwal Family Trust
- Dr. Ashar Agarwal Family Trust
- Dr Agarwal’s Eye Institute
- Dr Agarwal's Eye Institute Private Limited
Promoters Holding
Holding Pre Issue
37.72%
Holding Post Issue
32.50%
Dr Agarwals Healthcare IPO Objective
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:
- Repayment/prepayment, in part or full, of certain of the borrowings and
- General corporate purposes and unidentified inorganic acquisition.
Address / Contact Info
Dr. Agarwal's Health Care Limited
1st Floor, Buhari Towers,
No.4, Moores Road, Off
Greams Road, Near Asan
Memorial School,
Chennai 600006, Tamil Nadu
Phone: +91 44 4378 7777
Email: secretarial@dragarwal.com
Website: https://dragarwals.co.in/
IPO Snapshot
Book Running Lead Managers
- Morgan Stanley India Company Private Limited
- Jefferies India Private Limited
- Kotak Mahindra Capital Company Limited
- Motilal Oswal Investment Advisors Pvt Ltd
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Dr Agarwals Healthcare IPO is a Book-building IPO with a total issue size of ₹3027.26 crore. The Dr Agarwals Healthcare IPO price band is ₹382 to 402 per share. The Dr Agarwals Healthcare IPO subscription opens on Wed, Jan 29, 2025, and closes on Fri, Jan 31, 2025. The Dr Agarwals Healthcare IPO will be listed on the BSE,NSE. Kfin Technologies Limited is the registrar for the Dr Agarwals Healthcare IPO.
The Dr Agarwals Healthcare IPO opens on Wed, Jan 29, 2025 and closes on Fri, Jan 31, 2025
Dr Agarwals Healthcare IPO Price Band is ₹382 to 402 per share.
Dr Agarwals Healthcare IPO lot size is 35 shares, Retail investors need a minimum investment of ₹14070 based on the upper price band
The minimum investment for Dr Agarwals Healthcare IPO is ₹14070, based on one lot of 35 shares at the upper price band of ₹402 per share.
Investors can apply for the Dr Agarwals Healthcare IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Jan 31, 2025. The application amount remains blocked until the Dr Agarwals Healthcare IPO allotment is finalized.
Dr Agarwals Healthcare IPO issue size is ₹3027.26 crores.
Dr Agarwals Healthcare IPO allotment date is Wed, Jul 1, 2026.
The registrar for Dr Agarwals Healthcare IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited website to check Dr Agarwals Healthcare IPO allotment status, refund processing, and other IPO-related information.
The Dr Agarwals Healthcare IPO GMP (Grey Market Premium) is ₹-4 as of Tue, Feb 4, 2025. Based on the upper price band of ₹402 per share, the estimated Dr Agarwals Healthcare IPO listing price is ₹398, indicating a potential listing gain of approximately 0% over the issue price.